SFCM
TYRA icon

Seven Fleet Capital Management’s Tyra Biosciences TYRA Stock Holding History

Seven Fleet Capital Management’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.49M Buy
195,685
+116,125
+146% +$3.76M 2.35% 4
2025
Q4 		$2.09M Buy
+79,560
New +$1.46M 1.42% 11

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Seven Fleet Capital Management's TYRA Position: Q1 2026 in Review

Seven Fleet Capital Management increased its Tyra Biosciences (TYRA) stake by 146% in Q1 2026, buying an estimated $3.76M and bringing the position to 195,685 shares worth $7.49M. The position accounts for 2.35% of the portfolio, ranked #4.

Seven Fleet Capital Management first reported a position in TYRA in Q4 2025 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Seven Fleet Capital Management held 195,685 shares of Tyra Biosciences worth $7.49M as of Q1 2026.
  • Seven Fleet Capital Management bought 116,125 Tyra Biosciences shares in Q1 2026, an estimated $3.76M.
  • Tyra Biosciences made up 2.35% of Seven Fleet Capital Management's portfolio in Q1 2026, its #4 holding.
  • Seven Fleet Capital Management first reported a position in Tyra Biosciences in Q4 2025 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Seven Fleet Capital Management's 13F filing for Q1 2026, filed 15 May 2026.